A practical reference on GLP-1 receptor: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2025-11-28. Anything still debated is marked as such rather than presented as settled.
The company that developed the compound filed it as a long-acting analogue, and it gained first approval in 2017 for type 2 diabetes. Later authorisations from several regulators extended the indication to chronic weight management, and the World Health Organization added the glucagon-like peptide-1 receptor agonist drug class to its model list of essential medicines in 2023. Production uses solid-phase peptide synthesis followed by side-chain conjugation and chromatographic purification. Supply constraints and cost differences across regions are well documented. Literature on long-term outcomes continues to grow, with many trials reporting surrogate endpoints rather than hard clinical endpoints.
Semaglutide is a synthetic peptide of thirty-one amino acids that shares roughly ninety-four percent sequence identity with human glucagon-like peptide-1. Two substitutions resist enzymatic cleavage by dipeptidyl peptidase-4, and a fatty diacid side chain attached through a linker promotes binding to serum albumin. That albumin binding slows renal clearance and extends the circulating half-life from minutes to approximately one week. The structural changes are well established in the published literature. Whether the same modifications affect receptor signalling bias in ways that matter clinically remains an open question.
Pharmacological activity arises from agonism at the glucagon-like peptide-1 receptor, a G protein-coupled receptor expressed in the pancreas, the gastrointestinal tract, and the brainstem. Receptor activation raises intracellular cyclic adenosine monophosphate and enhances insulin release in a glucose-dependent manner, an effect that diminishes when blood glucose concentration is low. Other effects include slowed gastric emptying and hypothalamic satiety signalling. These pathways are described well. Receptor desensitisation rates across tissues, relative to the endogenous hormone, are still under investigation, and reported findings differ between laboratories.
Receptor activation follows the canonical Gs pathway: binding increases intracellular cyclic AMP, which promotes protein kinase A activity. In pancreatic beta cells this amplifies glucose-dependent insulin release, so secretion rises when blood glucose is high and changes little when it is low. The same signalling suppresses glucagon release from alpha cells and slows gastric emptying. Receptors in the hypothalamus and brainstem are thought to contribute to reduced appetite and lower energy intake. Which of these effects dominates clinical outcomes remains an area of active study.
Semaglutide is a synthetic peptide analogue of glucagon-like peptide-1, a gut hormone released by intestinal L cells after food intake. The natural hormone acts on pancreatic and central receptors but is degraded within minutes by dipeptidyl peptidase-4 and other peptidases. Semaglutide belongs to the class of long-acting GLP-1 receptor agonists, a group distinguished by structural changes that slow breakdown and extend circulation time. Its development followed earlier short-acting analogues and reflects a general strategy in peptide drug design: preserve receptor activity while blocking proteolytic clearance.
| Property | Value | Notes |
|---|---|---|
| Molecular class | 31-amino-acid peptide | Modified glucagon-like peptide-1 analogue |
| Molecular mass | approximately 4114 Da | Calculated for the free peptide backbone |
| Appearance | white to off-white powder | Typical of purified lyophilised peptide batches |
| Solubility class | freely soluble in water | Aqueous solubility improves at slightly alkaline pH |
| Typical storage | -20 degrees Celsius, dry, dark | Protect from repeated freeze-thaw cycles |
Two structural features account for the prolonged half-life of semaglutide. A modified amino acid at position 8 resists cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GLP-1. A fatty diacid side chain binds serum albumin, which limits renal clearance and protects the peptide from enzymatic breakdown. These modifications yield a plasma half-life of approximately one week in humans, allowing once-weekly administration. The relationship between plasma concentration and clinical effect varies between individuals, and sources of that variability are still being characterized.
Semaglutide is a synthetic peptide analog of glucagon-like peptide-1 (GLP-1), a hormone released from intestinal L-cells after food intake. The compound belongs to the incretin mimetic class and acts at GLP-1 receptors distributed across pancreatic, gastrointestinal, cardiovascular, and central nervous system tissues. Compared with native GLP-1, the molecule carries structural changes that extend its activity from minutes to roughly one week. It is studied for glycemic control in type 2 diabetes and for weight management, and its effects on cardiovascular and other outcomes remain active research areas.
Receptor binding triggers G protein signaling that raises intracellular cyclic AMP in pancreatic beta cells. Insulin release follows in a glucose-dependent manner, so secretion increases when blood glucose is elevated and diminishes when it is not. The same signaling suppresses glucagon release from alpha cells and slows gastric emptying, which blunts the post-meal glucose rise. In the brain, receptor activation in regions such as the arcuate nucleus is associated with reduced appetite and lower energy intake. How much each of these effects contributes to overall weight change is not fully settled.
Semaglutide belongs to the glucagon-like peptide-1 receptor agonist class, a group of synthetic peptides that imitate an incretin hormone released by intestinal L cells after food intake. Native GLP-1 circulates for only a few minutes because dipeptidyl peptidase-4 cleaves it rapidly. The hormone acts on pancreatic islets, the gastrointestinal tract, and several brain regions. Because the natural peptide is short-lived, development work concentrated on analogues that keep receptor activity while resisting enzymatic breakdown and renal clearance.
The semaglutide sequence is a 31-residue analogue of human GLP-1, altered at three positions relative to the parent hormone. Aminoisobutyric acid replaces alanine at position 8, arginine replaces lysine at position 34, and a lipophilic diacid is attached to lysine 26 through a short linker. These features are reported consistently in the structural literature. The position 8 substitution blocks recognition by dipeptidyl peptidase-4, while the attached chain drives strong, reversible association with a carrier protein in blood.
Receptor activation raises intracellular cyclic AMP through Gs coupling, which promotes glucose-dependent insulin release and suppresses glucagon secretion when blood glucose is elevated. Effects outside the pancreas include slower gastric emptying and altered appetite signalling in the hypothalamus and hindbrain. The relative contribution of each tissue to overall metabolic outcomes remains an area of active investigation. Central mechanisms in particular are inferred mainly from animal models and indirect human measures rather than direct observation.
After fascism came to power with the March on Rome on 28 October 1922, a centralized dictatorial regime began in the southern region, strengthened after the assassination of socialist deputy Giacomo Matteotti in 1924 and formalized with the Leggi fascistissime of 1925–1926, which outlawed all political parties except the fascist party, censored the press, and banned trade unions and strikes. In addition, mayoral elections were abolished, replaced by podestà, appointed by the prefect, with absolute powers in political and economic management. During this period, the most representative Calabrian political personality was Michele Bianchi, a native of Belmonte Calabro, who was a close associate of Mussolini and quadrumviral of the 1922 March on Rome, in addition to holding the posts of deputy, undersecretary at the Ministry of the Interior and, finally, minister of Public Works. In this capacity, which he held until his death in 1930, he had a number of infrastructures built in Calabria, such as the Camigliatello Silano ski resort (initially called Camigliatello Bianchi), as well as promoting public works in Cosenza while Tommaso Arnoni was mayor (1925–1934). In December 1924 a false rumor spread in Reggio Calabria that Benito Mussolini had resigned as Prime Minister because of the Matteotti affair, leading to joyous all-night celebrations. In the morning, the people learned that Mussolini was still prime minister. Several Fascist officials were dismissed for not suppressing the celebrations.
=== Early history (2017–2020) === Hims, Inc. was founded in November 2017 by Andrew Dudum, Jack Abraham, and Hilary Coles as part of Atomic Labs, a San Francisco venture studio co-founded by Dudum and Abraham. It initially offered generic prescription treatments for erectile dysfunction and hair loss alongside skincare products, marketed to millennial men through a direct-to-consumer brand. Hims received $7 million in seed funding from investors including Kirsten Green of Forerunner Ventures and Josh Kushner's Thrive Capital. In 2018, Hims launched Hers, a brand targeting women's health needs including birth control, skincare, and hair regrowth treatments. In January 2019, Hims raised $100 million in a Series C funding round at a $1 billion pre-money valuation. Later that year, the company expanded internationally with a launch in the United Kingdom. In April 2020, amid the COVID-19 pandemic, Hims & Hers expanded into mental health with a rollout of free anonymous group therapy sessions, later adding online psychiatry consultations and, in 2021, individual teletherapy services.
=== Chemical reactions === Diallyl disulfide can be readily oxidized to allicin with hydrogen peroxide or peracetic acid. Allicin in turn can hydrolyze giving diallyl disulfide and trisulfide. Reaction of diallyl disulfide with liquid sulfur gives a mixture containing diallyl polysulfides with as many as 22 sulfur atoms in a continuous chain identified. When diallyl disulfide is heated it decomposes giving a complex mixture. The carbon-sulfur bond of diallyl disulfide is 16 kcal mol−1 weaker than the sulfur-sulfur bond (46 kcal mol−1 versus 62 kcal mol−1, respectively), with the consequence that on heating diallyl disulfide gives the allyldithio radical (AllSS•), which through addition to the double bonds in diallyl disulfide followed by fragmentation and subsequent reactions generates numerous organosulfur compounds, many of which are found in trace amounts in distilled garlic oil. In the presence of a catalyst, diallyl disulfide can combine with alkyl halides forming 1-alkylthio-3-allylthio-1-propene and 1,3-di(alkylthio)propene.
Following the dismissal of the Bellido cabinet, the new Vásquez cabinet hoped to replace Bellido's ultra-confrontational approach to Congress with a more conciliatory approach. Prime Minister Mirtha Vásquez held a meeting with members of Congress to negotiate on the question of trust and the presidential impeachment. Vásquez proposed a new version of the question of trust which she claimed would not cause an imbalance of power. However, it became clear that Congress would stick to their own bill. Free Peru's ally, Together for Peru, proposed a bill that would dissolve Congress if the President was impeached for moral or physical incapacity. Following that, new parliamentary elections would be held. The bill failed to pass. On 22 October 2021, the government presented a lawsuit before the Constitutional Court (CT) that Congress' reinterpretation of the question of confidence was unconstitutional. The CT unanimously admitted the case on 28 October 2021. On 2 November 2021, Eloy Espinosa-Saldaña, who was appointed rapporteur of the case, asked Congress to quickly respond to the lawsuit. Meanwhile, the Minister of Justice, Aníbal Torres, claimed that if the CT respected its past judgements, it should declare the unconstitutionality of the law that reinterprets the question of trust. On 16 November 2021, Congress formalized changes that would allow itself to reject a question of confidence as inadmissible if it's not in line with the restrictions previously passed by itself. Said restrictions are currently being challenged in the Constitutional Court.
== Cleaning == Like all protein-based fibers (wool, silk), products made from vicuña wool must be cleaned by dry cleaning (water-free) or by hand in tepid water with a mild detergent. Detergents which contain bleach or enzymes (protein-degrading enzymes) are unsuitable, as they damage the hair structure. In the case of hydrophilic textiles, such as textiles made of wool, water contact can lead to thread shortening and thus to shrinkage of the textile due to swelling and the shrinkage that follows during drying. Shrinkage is intensified in clothes dryers. Due to a tendency to felting, textiles made of vicuña wool should not be wrung or rubbed, but can be dabbed.
Sources: en.wikipedia.org
. However, away from this reference point, errors will accumulate over time thus convergence test is needed to find an optimal time step for more accurate results. Among these three reproduction numbers,
Corn and sugar cane are C4 plants, whereas the plants used by bees to produce honey, as well as sugar beet, are predominantly C3 plants. Sugars derived from C4 plants alter the isotopic ratio of sugars in honey but do not affect the isotopic ratio of proteins. In unadulterated honey, the carbon isotopic ratios of sugars and proteins are expected to match. Using this method, adulteration levels as low as seven per cent can be detected.
Since the December 2013 announcement that Zaxbys would begin to offer the Coca-Cola Freestyle machine at their locations, the decor in the fountain drink dispensing area has been dominated by that distinctive dispenser and other Coca-Cola branding. The company reintroduced milkshakes to its menu in 2025.
An mRNA vaccine is a type of vaccine that uses a copy of a molecule called messenger RNA (mRNA) to produce an immune response. The vaccine delivers molecules of antigen-encoding mRNA into cells, which use the designed mRNA as a blueprint to build foreign protein that would normally be produced by a pathogen (such as a virus) or by a cancer cell. These protein molecules stimulate an adaptive immune response that teaches the body to identify and destroy the corresponding pathogen or cancer cells. The mRNA is delivered by a co-formulation of the RNA encapsulated in lipid nanoparticles that protect the RNA strands and help their absorption into the cells.
=== Hemolytic effect === Guanacastepene A also exhibits a significant toxic side effect in that it possesses pronounced hemolytic activity, which leads to the lysis of erythrocytes (human red blood cells). The strongest hemolytic effect was observed in laboratory tests at concentrations between 8 and 32 µg/ml. However, this effect diminishes at very high concentrations (above 64 µg/ml) as well as at very low concentrations (below 8 µg/ml). The mechanism of cell membrane damage is not selective enough for bacteria; eukaryotic cell membranes are also affected by the damaging effect of Guanacastepene A.
Sources: en.wikipedia.org
It is a glucagon-like peptide-1 receptor agonist, often grouped with the incretin mimetics. Its backbone is modified from the human hormone to resist enzymatic degradation and to bind albumin. These two features distinguish it from the native peptide.
No. It shares high sequence identity but carries non-natural modifications that alter its stability and clearance. The naturally occurring hormone is broken down within minutes, while the synthetic analogue circulates far longer.
Attachment to serum albumin reduces renal filtration of the peptide and shields it from enzymatic breakdown. The consequence is a much longer interval between administrations than unmodified peptides allow. The precise contribution of binding affinity to overall duration is still being quantified.
Native GLP-1 is a short-lived peptide cleared within one to two minutes by dipeptidyl peptidase-4 and related enzymes. Semaglutide keeps the receptor-binding backbone but adds substitutions and a lipid chain. These changes block the main cleavage site and allow reversible albumin binding, extending the half-life to roughly 165 hours.